Related Experiment Videos
Tetanus antibodies as a marker of potential efficacy of killed polio immunization
Insights
Antibody levels to tetanus toxin in infants were remarkably high, suggesting this marker is unreliable for assessing immunization effectiveness. This contrasts with lower immunity rates observed for polio vaccination in previous studies.
Area of Science:
- Immunology
- Public Health
- Pediatrics
Background:
- Assessing vaccine efficacy in infant populations is crucial for public health.
- Parenteral immunization strategies aim to induce protective antibody levels.
- Previous studies indicated variable immunity levels for other childhood vaccines.
Purpose of the Study:
- To evaluate the reliability of anti-tetanus toxin antibody levels as a marker for parenteral immunization efficacy in South African black infants.
- To compare tetanus antibody levels with immunity rates for other common childhood vaccines.
Main Methods:
- A randomized sample of 1212 infant sera (24-35 months) from the RSA was analyzed.
- Antibody levels were quantified using enzyme-linked immunosorbent assay (ELISA).
- Results were compared with historical data on polio immunity.
Main Results:
- Over 99% of infants exhibited protective levels of anti-tetanus toxin antibodies.
- This high seropositivity contrasts sharply with lower reported immunity rates for polio (59-80% tritypic, 70-84% mono-/bi-typic).
Conclusions:
- Anti-tetanus toxin antibody levels appear to be an unreliable marker for assessing parenteral immunization efficacy in this population.
- The unexpectedly high prevalence of tetanus antibodies warrants further investigation into potential contributing factors.
Abstract:
The use of antibodies to tetanus toxin as a marker of efficacy of parenteral immunization was examined in a randomized sample of 1212 sera representative of the total black infant population of the RSA between 24 and 35 months. All but one of these sera had protective levels of antibodies measured by enzyme-linked immunosorbent assay. In contrast, in a previous study only 59-80% had tritypic immunity to polio and 70-84% mono- or bitypic immunity. Thus, this serological marker was found to be unreliable and some possibilities for this remarkably high level of antitetanus antibodies are considered.